Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022)
Weed's (BUDZ) quarterly Net Equity Issued and Repurchased came in at $10000.0 in Q2 2022, down 94.12% year-on-year from $170000.0 in Q2 2021, and down 66.67% quarter-over-quarter from $30000.0 in Q1 2022.
Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends
Weed's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $10000.0 for Q2 2022.
- On a quarterly basis, Net Equity Issued and Repurchased fell 94.12% year-over-year to $10000.0 in Q2 2022; TTM through Dec 2022 was $40000.0, a 92.86% decrease from a year earlier, with the FY2022 full-year figure at $40000.0, down 92.86% from the prior year.
- Net Equity Issued and Repurchased eased to $10000.0 in Q2 2022 per BUDZ's latest filing, from $30000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $2.0 million in Q4 2018 and bottomed at $10000.0 in Q2 2022.
- The 5-year median for Net Equity Issued and Repurchased is $100000.0 (2020), against an average of $381847.1.
- Across the five-year window, Net Equity Issued and Repurchased jumped 1381.37% in 2018 and slumped 96.25% in 2019, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $2.0 million in 2018, then slumped by 96.25% to $74999.0 in 2019, then surged by 33.34% to $100000.0 in 2020, then dropped by 20.0% to $80000.0 in 2021, then slumped by 87.5% to $10000.0 in 2022.
- Per Business Quant, the three latest BUDZ Net Equity Issued and Repurchased figures stand at $10000.0 (Q2 2022), $30000.0 (Q1 2022), and $80000.0 (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 170,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 55,000.00 |
| Jun 30, 2020 | 55,000.00 |
| Mar 31, 2020 | 40,000.00 |
| Mar 31, 2020 | 40,000.00 |